• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Playing the Hand You're Dealt

Check out just a few of the year-to-date moves coming into Thursday on 8 companies you've never heard of before the last week or two.
By TIMOTHY COLLINS
Feb 27, 2020 | 10:51 AM EST
Stocks quotes in this article: GILD, APT, CODX, TEDU, MRNA, VXRT, VIR, NVAX, NNVC

Traders have a unique perspective of the world, almost a dual personality. With every news event, most traders have two reactions:

  1. How does this impact me/my family/my friends/my life?
  2. How can I profit from it?

I touched on this idea before when it comes to the coronavirus. I don't believe anyone should be rooting on a pandemic and death to make money or strengthen their belief in their political opinion, but life is what it is for traders, so while we may not like what's happening around us or secretly hope things get worse, we still have to manage our trading.

Simply put: you play the hand you're dealt.

Right now, that hand includes the coronavirus, and traders are betting aggressively early in the round. Take a look at some of the gains today on big winners from Wednesday's trade as coronavirus-related plays.

What you'll find in this list is a lot of small biotechs that have issued press releases or been linked to working on a treatment or cure for the coronavirus. Additionally, there are a couple of Chinese online learning companies, a China health insurance company, shelf-stable food company, and makers of face masks.

Check out just a few of the year-to-date moves coming into Thursday on companies you've never heard of before the last week or two:

Alpha Pro Tech (APT) (maker of facemasks) +261%

Co-Diagonostics (CODX) (test kit) +894%

Tarena Intl (TEDU) (online learning) +95%

Moderna (MRNA) (biotech) +49%

Vaxart (VXRT) (biotech) +371%

Vir Biotech (VIR) (biotech) +178%

Novavax (NVAX) (biotech) +132%

NanoViricides (NNVC) (biotech) +265%

The folks in these names are participating in the age-old Greater Fool Theory trading strategy. Outside of an epic short-squeeze, this is a huge risk and absolutely huge reward method, but it's important to understand most of the names are trading on hype and hope. One year from now, probably sooner than they, I would wager every name except one on this list is lower. Significantly lower. That face does not mean a top is in any of these names yet. It's is important to understand that if you are buying today, you are banking on the fact that another momentum trader will pay you more for those shares in a few hours, a few days, or even a few weeks, but no one is buying these names as investments or long-term holdings outside of maybe Gilead Sciences (GILD) .

For all the 50%, 75%, and 100% we've seen and still might see on these names, there are going to be an ample amount of -20%, -40%, and -50% days in the near future. Those with the losses will be crowned the fool.

I'm not advocating against trading these. Heck, I'll trade a stock that deals with salvaging the hoards of squirrels if I think I can make money on it, but if you are in the space, please understand the risk. Leaving your desk to do something as simple as using the restroom could result in a price that is 10% or 20% changed by the time you return, possibly to your benefit and possibly not. When the reversal of reality does it, it will hit hard and it will hit fast. The challenge becomes whether it occurs here or 200% higher from here.

Only a few names have options, so there's not a lot you can do to protect yourself, but those options are telling. For instance, Alpha Pro Tech current has an ask of $0.70 on the March 20, $7.50 puts. Those are puts that expire in 22 days and sit more than $12 (61%) OUT-of-the-money. The April $5 puts are asking $0.45. The March 20 $20 straddle is pricing in a move of 68% over the next 22 days.

All I'm saying is be careful out there and good luck if you are involved in these names. I hope they treat you well!

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Timothy Collins had no position in the securities mentioned.

TAGS: Investing | Markets | Options | Stocks | Trading | Coronavirus

More from Investing

Market Mistrust May Make for a Move Higher

James "Rev Shark" DePorre
May 26, 2022 4:41 PM EDT

This lack of faith in the market could help put more pressure on the upside, here's how.

Raising HAL

Bruce Kamich
May 26, 2022 3:43 PM EDT

Shares of Halliburton have the energy to make new highs, according to the charts.

When the Markets Are a Game of Risk, Keep This Fund in Your Quiver

Mark Abssy
May 26, 2022 3:15 PM EDT

This ETF manages risk in a nuanced way.

At Some Point, Commodities Find Balance, Too

Maleeha Bengali
May 26, 2022 2:23 PM EDT

Don't forget about the importance of timing and demand as we look at wild moves in oil from the Covid lows to now.

AbbVie's Correction Appears to Be Over: Here's Where the Stock Could Be Headed

Bruce Kamich
May 26, 2022 2:19 PM EDT

Should you be a buyer?

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 02:46 PM EDT STEPHEN GUILFOYLE

    We're Shedding Some of This Holding on Strength

    Check out the Stocks Under $10 portfolio here!
  • 11:33 AM EDT PETER TCHIR

    Thoughts Ahead of the Fed Minutes

    Recent economic and earnings issues are convincing...
  • 02:24 PM EDT PAUL PRICE

    An Interesting Chart

    I'm betting heavily that stocks will be way up aga...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login